24 results on '"Dreses-Werringloer U"'
Search Results
2. Comparative genomic analysis of human Chlamydia pneumoniae isolates from respiratory, brain and cardiac tissues
- Author
-
Roulis, E, Bachmann, NL, Myers, GSA, Huston, W, Summersgill, J, Hudson, A, Dreses-Werringloer, U, Polkinghorne, A, and Timms, P
- Subjects
Genetics & Heredity ,Recombination, Genetic ,Respiratory System ,Brain ,Heart ,Sequence Analysis, DNA ,Genomics ,Chlamydophila pneumoniae ,Atherosclerosis ,Adaptation, Physiological ,Polymorphism, Single Nucleotide ,respiratory tract diseases ,Evolution, Molecular ,Species Specificity ,Alzheimer Disease ,Mutation ,Host-Pathogen Interactions ,Humans ,Chlamydophila Infections ,Phylogeny ,Genome, Bacterial - Abstract
© 2015 Elsevier Inc. Chlamydia pneumoniae is an obligate intracellular bacterium implicated in a wide range of human diseases including atherosclerosis and Alzheimer's disease. Efforts to understand the relationships between C. pneumoniae detected in these diseases have been hindered by the availability of sequence data for non-respiratory strains. In this study, we sequenced the whole genomes for C. pneumoniae isolates from atherosclerosis and Alzheimer's disease, and compared these to previously published C. pneumoniae genomes. Phylogenetic analyses of these new C. pneumoniae strains indicate two sub-groups within human C. pneumoniae, and suggest that both recombination and mutation events have driven the evolution of human C. pneumoniae. Further fine-detailed analyses of these new C. pneumoniae sequences show several genetically variable loci. This suggests that similar strains of C. pneumoniae are found in the brain, lungs and cardiovascular system and that only minor genetic differences may contribute to the adaptation of particular strains in human disease.
- Published
- 2015
3. Molecular signatures in post-mortem brain tissue of younger individuals at high risk for Alzheimer's disease as based on APOE genotype
- Author
-
Conejero-Goldberg, C, primary, Hyde, T M, additional, Chen, S, additional, Dreses-Werringloer, U, additional, Herman, M M, additional, Kleinman, J E, additional, Davies, P, additional, and Goldberg, T E, additional
- Published
- 2010
- Full Text
- View/download PDF
4. Optimised sample preparation of synovial fluid for detection of Chlamydia trachomatis DNA by polymerase chain reaction
- Author
-
Kuipers, J. G, primary, Nietfeld, L., additional, Dreses-Werringloer, U., additional, Koehler, L., additional, Wollenhaupt, J., additional, Zeidler, H., additional, and Hammer, M., additional
- Published
- 1999
- Full Text
- View/download PDF
5. Studies of persistent infection by Chlamydia trachomatis serovar K in TPA-differentiated U937 cells and the role of IFN-
- Author
-
NETTELNBREKER, E., primary, ZEIDLER, H., additional, BARTELS, H., additional, DRESES-WERRINGLOER, U., additional, DaUBENER, W., additional, HOLTMANN, H., additional, and KOHLER, L., additional
- Published
- 1998
- Full Text
- View/download PDF
6. Calcium signaling in neurodegeneration
- Author
-
Dreses-Werringloer Ute, Marambaud Philippe, and Vingtdeux Valérie
- Subjects
Neurology. Diseases of the nervous system ,RC346-429 ,Geriatrics ,RC952-954.6 - Abstract
Abstract Calcium is a key signaling ion involved in many different intracellular and extracellular processes ranging from synaptic activity to cell-cell communication and adhesion. The exact definition at the molecular level of the versatility of this ion has made overwhelming progress in the past several years and has been extensively reviewed. In the brain, calcium is fundamental in the control of synaptic activity and memory formation, a process that leads to the activation of specific calcium-dependent signal transduction pathways and implicates key protein effectors, such as CaMKs, MAPK/ERKs, and CREB. Properly controlled homeostasis of calcium signaling not only supports normal brain physiology but also maintains neuronal integrity and long-term cell survival. Emerging knowledge indicates that calcium homeostasis is not only critical for cell physiology and health, but also, when deregulated, can lead to neurodegeneration via complex and diverse mechanisms involved in selective neuronal impairments and death. The identification of several modulators of calcium homeostasis, such as presenilins and CALHM1, as potential factors involved in the pathogenesis of Alzheimer's disease, provides strong support for a role of calcium in neurodegeneration. These observations represent an important step towards understanding the molecular mechanisms of calcium signaling disturbances observed in different brain diseases such as Alzheimer's, Parkinson's, and Huntington's diseases.
- Published
- 2009
- Full Text
- View/download PDF
7. Amyloid-beta peptide degradation in cell cultures by mycoplasma contaminants
- Author
-
Davies Peter, Dreses-Werringloer Ute, Zhao Haitian, and Marambaud Philippe
- Subjects
Medicine ,Biology (General) ,QH301-705.5 ,Science (General) ,Q1-390 - Abstract
Abstract Background Cell cultures have become an indispensable tool in Alzheimer's disease research for studying amyloid-β (Aβ) metabolism. It is estimated that up to 35% of cell cultures in current use are infected with various mycoplasma species. In contrast with common bacterial and fungal infections, contaminations of cell cultures with mycoplasmas represent a challenging issue in terms of detectability and prevention. Mycoplasmas are the smallest and simplest self-replicating bacteria and the consequences of an infection for the host cells are variable, ranging from no apparent effect to induction of apoptosis. Findings Here we present evidence that mycoplasmas from a cell culture contamination are able to efficiently and rapidly degrade extracellular Aβ. As a result, we observed no accumulation of Aβ in the conditioned medium of mycoplasma-positive cells stably transfected with the amyloid-β precursor protein (APP). Importantly, eradication of the mycoplasma contaminant – identified as M. hyorhinis – by treatments with a quinolone-based antibiotic, restored extracellular Aβ accumulation in the APP-transfected cells. Conclusion These data show that mycoplasmas degrade Aβ and thus may represent a significant source of variability when comparing extracellular Aβ levels in different cell lines. On the basis of these results, we recommend assessment of mycoplasma contaminations prior to extracellular Aβ level measurements in cultured cells.
- Published
- 2008
- Full Text
- View/download PDF
8. Comparative genomic analysis of human Chlamydia pneumoniae isolates from respiratory, brain and cardiac tissues.
- Author
-
Roulis E, Bachmann NL, Myers GS, Huston W, Summersgill J, Hudson A, Dreses-Werringloer U, Polkinghorne A, and Timms P
- Subjects
- Adaptation, Physiological genetics, Alzheimer Disease microbiology, Atherosclerosis microbiology, Brain microbiology, Chlamydophila Infections microbiology, Chlamydophila pneumoniae classification, Chlamydophila pneumoniae physiology, Evolution, Molecular, Heart microbiology, Host-Pathogen Interactions, Humans, Mutation, Phylogeny, Polymorphism, Single Nucleotide, Recombination, Genetic, Respiratory System microbiology, Species Specificity, Chlamydophila pneumoniae genetics, Genome, Bacterial genetics, Genomics methods, Sequence Analysis, DNA methods
- Abstract
Chlamydia pneumoniae is an obligate intracellular bacterium implicated in a wide range of human diseases including atherosclerosis and Alzheimer's disease. Efforts to understand the relationships between C. pneumoniae detected in these diseases have been hindered by the availability of sequence data for non-respiratory strains. In this study, we sequenced the whole genomes for C. pneumoniae isolates from atherosclerosis and Alzheimer's disease, and compared these to previously published C. pneumoniae genomes. Phylogenetic analyses of these new C. pneumoniae strains indicate two sub-groups within human C. pneumoniae, and suggest that both recombination and mutation events have driven the evolution of human C. pneumoniae. Further fine-detailed analyses of these new C. pneumoniae sequences show several genetically variable loci. This suggests that similar strains of C. pneumoniae are found in the brain, lungs and cardiovascular system and that only minor genetic differences may contribute to the adaptation of particular strains in human disease., (Copyright © 2015 Elsevier Inc. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
9. Effect of the CALHM1 G330D and R154H human variants on the control of cytosolic Ca2+ and Aβ levels.
- Author
-
Vingtdeux V, Tanis JE, Chandakkar P, Zhao H, Dreses-Werringloer U, Campagne F, Foskett JK, and Marambaud P
- Subjects
- Amyloid beta-Peptides, Animals, Cell Line, Gene Frequency, HEK293 Cells, Humans, Xenopus, Alzheimer Disease genetics, Calcium metabolism, Calcium Channels genetics, Calcium Signaling genetics, Membrane Glycoproteins genetics
- Abstract
CALHM1 is a plasma membrane voltage-gated Ca2+-permeable ion channel that controls amyloid-β (Aβ) metabolism and is potentially involved in the onset of Alzheimer's disease (AD). Recently, Rubio-Moscardo et al. (PLoS One (2013) 8: e74203) reported the identification of two CALHM1 variants, G330D and R154H, in early-onset AD (EOAD) patients. The authors provided evidence that these two human variants were rare and resulted in a complete loss of CALHM1 function. Recent publicly available large-scale exome sequencing data confirmed that R154H is a rare CALHM1 variant (minor allele frequency (MAF) = 0.015%), but that G330D is not (MAF = 3.5% in an African American cohort). Here, we show that both CALHM1 variants exhibited gating and permeation properties indistinguishable from wild-type CALHM1 when expressed in Xenopus oocytes. While there was also no effect of the G330D mutation on Ca2+ uptake by CALHM1 in transfected mammalian cells, the R154H mutation was associated with defects in the control by CALHM1 of both Ca2+ uptake and Aβ levels in this cell system. Together, our data show that the frequent CALHM1 G330D variant has no obvious functional consequences and is therefore unlikely to contribute to EOAD. Our data also demonstrate that the rare R154H variant interferes with CALHM1 control of cytosolic Ca2+ and Aβ accumulation. While these results strengthen the notion that CALHM1 influences Aβ metabolism, further investigation will be required to determine whether CALHM1 R154H, or other natural variants in CALHM1, is/are associated with EOAD.
- Published
- 2014
- Full Text
- View/download PDF
10. CALHM1 controls the Ca²⁺-dependent MEK, ERK, RSK and MSK signaling cascade in neurons.
- Author
-
Dreses-Werringloer U, Vingtdeux V, Zhao H, Chandakkar P, Davies P, and Marambaud P
- Subjects
- Animals, Calcium, Calcium Channels genetics, Cell Line, Cells, Cultured, Female, Humans, Membrane Glycoproteins genetics, Mice, Mice, Knockout, Mitogen-Activated Protein Kinase 1 genetics, Mitogen-Activated Protein Kinase 3 genetics, Neurons drug effects, Ribosomal Protein S6 Kinases, 90-kDa genetics, Ruthenium Red pharmacology, Signal Transduction drug effects, Signal Transduction genetics, Calcium Channels metabolism, Membrane Glycoproteins metabolism, Mitogen-Activated Protein Kinase 1 metabolism, Mitogen-Activated Protein Kinase 3 metabolism, Neurons metabolism, Ribosomal Protein S6 Kinases, 90-kDa metabolism
- Abstract
Calcium homeostasis modulator 1 (CALHM1) is a Ca(2+) channel controlling neuronal excitability and potentially involved in the pathogenesis of Alzheimer's disease (AD). Although strong evidence indicates that CALHM1 is required for neuronal electrical activity, its role in intracellular Ca(2+) signaling remains unknown. In the present study, we show that in hippocampal HT-22 cells, CALHM1 expression led to a robust and relatively selective activation of the Ca(2+)-sensing kinases ERK1/2. CALHM1 also triggered activation of MEK1/2, the upstream ERK1/2-activating kinases, and of RSK1/2/3 and MSK1, two downstream effectors of ERK1/2 signaling. CALHM1-mediated activation of ERK1/2 signaling was controlled by the small GTPase Ras. Pharmacological inhibition of CALHM1 permeability using Ruthenium Red, Zn(2+), and Gd(3+), or expression of the CALHM1 N140A and W114A mutants, which are deficient in mediating Ca(2+) influx, prevented the effect of CALHM1 on the MEK, ERK, RSK and MSK signaling cascade, demonstrating that CALHM1 controlled this pathway via its channel properties. Importantly, expression of CALHM1 bearing the natural P86L polymorphism, which leads to a partial loss of CALHM1 function and is associated with an earlier age at onset in AD patients, showed reduced activation of ERK1/2, RSK1/2/3, and MSK1. In line with these results obtained in transfected cells, primary cerebral neurons isolated from Calhm1 knockout mice showed significant impairments in the activation of MEK, ERK, RSK and MSK signaling. The present study identifies a previously uncharacterized mechanism of control of Ca(2+)-dependent ERK1/2 signaling in neurons, and further establishes CALHM1 as a critical ion channel for neuronal signaling and function.
- Published
- 2013
- Full Text
- View/download PDF
11. Identification of potent small-molecule inhibitors of STAT3 with anti-inflammatory properties in RAW 264.7 macrophages.
- Author
-
Capiralla H, Vingtdeux V, Venkatesh J, Dreses-Werringloer U, Zhao H, Davies P, and Marambaud P
- Subjects
- Animals, Blotting, Western, Cell Line, Cell Proliferation drug effects, Cell Survival drug effects, Dose-Response Relationship, Drug, Enzyme-Linked Immunosorbent Assay, HEK293 Cells, Humans, I-kappa B Kinase metabolism, I-kappa B Proteins metabolism, Interleukin-6 metabolism, Lipopolysaccharides pharmacology, Macrophages metabolism, Mice, NF-KappaB Inhibitor alpha, Phagocytosis drug effects, Phosphorylation drug effects, STAT1 Transcription Factor metabolism, STAT3 Transcription Factor metabolism, Tumor Necrosis Factor-alpha metabolism, Aminophenols pharmacology, Anti-Inflammatory Agents pharmacology, Hydrazones pharmacology, Macrophages drug effects, STAT3 Transcription Factor antagonists & inhibitors
- Abstract
Signal transducer and activator of transcription 3 (STAT3) is a key mediator of the inflammatory response of macrophages and other immune cell types. The naturally occurring polyphenol resveratrol is associated with anti-proliferative and anti-inflammatory properties via mechanisms implicating inhibition of STAT3 signaling. Here, we report that the small-molecule analogs of resveratrol, RSVA314 and RSVA405, are potent inhibitors of STAT3. RSVA314 and RSVA405 inhibited both constitutive and stimulated STAT3 activity in HEK293 cells and lipopolysaccharide-stimulated RAW 264.7 macrophages, respectively. The small-molecule analogs inhibited STAT3 nearly 50 times more potently than did resveratrol (apparent IC(50) ~0.5 μM). We further show that RSVA405 interfered with the inflammatory response by RAW 264.7 cells upon lipopolysaccharide stimulation by inhibiting IκB kinase and IκBα phosphorylation and by decreasing the expression of several cytokines, including the NF-κB target genes tumor necrosis factor α and interleukin-6. Downstream activation of STAT1 upon lipopolysaccharide stimulation was also inhibited by RSVA405. Consequently, RSVA405 significantly interfered with the phagocytotic activity and proliferation of lipopolysaccharide-activated RAW 264.7 macrophages. Finally, we found that the effect of the two small-molecule analogs on STAT3 phosphorylation could be prevented by inhibitors of protein tyrosine phosphatases, indicating that the small molecules acted by promoting dephosphorylation of STAT3 by protein tyrosine phosphatases., (© 2012 The Authors Journal compilation © 2012 FEBS.)
- Published
- 2012
- Full Text
- View/download PDF
12. CALHM1 P86L polymorphism modulates CSF Aβ levels in cognitively healthy individuals at risk for Alzheimer's disease.
- Author
-
Koppel J, Campagne F, Vingtdeux V, Dreses-Werringloer U, Ewers M, Rujescu D, Hampel H, Gordon ML, Christen E, Chapuis J, Greenwald BS, Davies P, and Marambaud P
- Subjects
- Aged, Alzheimer Disease physiopathology, Amyloid Precursor Protein Secretases cerebrospinal fluid, Apolipoproteins E genetics, Aspartic Acid Endopeptidases cerebrospinal fluid, Biomarkers cerebrospinal fluid, Cognition physiology, Cohort Studies, Female, Gene Frequency, Genetic Predisposition to Disease genetics, Genotype, Humans, Male, Middle Aged, Peptide Fragments cerebrospinal fluid, Risk Factors, Alzheimer Disease cerebrospinal fluid, Alzheimer Disease genetics, Amyloid beta-Peptides cerebrospinal fluid, Calcium Channels genetics, Membrane Glycoproteins genetics, Polymorphism, Single Nucleotide
- Abstract
The calcium homeostasis modulator 1 (CALHM1) gene codes for a novel cerebral calcium channel controlling intracellular calcium homeostasis and amyloid-β (Aβ) peptide metabolism, a key event in the etiology of Alzheimer's disease (AD). The P86L polymorphism in CALHM1 (rs2986017) initially was proposed to impair CALHM1 functionally and to lead to an increase in Aβ accumulation in vitro in cell lines. Recently, it was reported that CALHM1 P86L also may influence Aβ metabolism in vivo by increasing Aβ levels in human cerebrospinal fluid (CSF). Although the role of CALHM1 in AD risk remains uncertain, concordant data have now emerged showing that CALHM1 P86L is associated with an earlier age at onset of AD. Here, we have analyzed the association of CALHM1 P86L with CSF Aβ in samples from 203 AD cases and 46 young cognitively healthy individuals with a positive family history of AD. We failed to detect an association between the CALHM1 polymorphism and CSF Aβ levels in AD patients. Our data, however, revealed a significant association of CALHM1 P86L with elevated CSF Aβ42 and Aβ40 in the normal cohort at risk for AD. This work shows that CALHM1 modulates CSF Aβ levels in presymptomatic individuals, strengthening the notion that CALHM1 is involved in AD pathogenesis. These data further demonstrate the utility of endophenotype-based approaches focusing on CSF biomarkers for the identification or validation of risk factors for AD.
- Published
- 2011
- Full Text
- View/download PDF
13. Performance-based measures of everyday function in mild cognitive impairment.
- Author
-
Goldberg TE, Koppel J, Keehlisen L, Christen E, Dreses-Werringloer U, Conejero-Goldberg C, Gordon ML, and Davies P
- Subjects
- Aged, Aged, 80 and over, Alzheimer Disease psychology, Analysis of Variance, Female, Humans, Male, Middle Aged, Neuropsychological Tests, Psychological Tests, Psychomotor Performance, ROC Curve, Regression Analysis, Severity of Illness Index, Activities of Daily Living psychology, Cognition Disorders psychology
- Abstract
Objective: The view that everyday function is preserved in mild cognitive impairment may be problematic. The objectives of this study were to determine the magnitude of impairment in everyday function in patients with mild cognitive impairment and Alzheimer's disease using a novel sensitive performance-based measure (the UCSD Performance-Based Skills Assessment; UPSA), contrast it with use of an informant-based measure (the Alzheimer's Disease Cooperative Study-Activities of Daily Living Inventory; ADCS-ADL), and model the relationship between cognitive measures and the performance-based measure., Method: Fifty cognitively normal elders, 26 patients who met criteria for amnestic mild cognitive impairment, and 22 patients who suffered from mild to moderate Alzheimer's disease were assessed on the UPSA, the ADCS-ADL, and a battery of neurocognitive tests., Results: Patients with mild cognitive impairment had significant impairments on the UPSA but not on the ADCS-ADL. The magnitude of the effect size between the cognitively healthy and the mild cognitive impairment group for the UPSA was large (d=0.86). A strong and significant relationship was observed between cognitive performances in speed (R(2)=0.37), episodic memory (R(2)=0.10), and semantic processing (R(2)=0.03) and UPSA score using multiple regression models. The psychometric properties of the UPSA were acceptable, as were its sensitivity and specificity in contrasts between cognitively normal elders and patients with mild cognitive impairment and between the latter group and patients with Alzheimer's disease., Conclusions: These findings indicate that performance-based measures of function may be a sensitive tool in studies of Alzheimer's disease and mild cognitive impairment and suggest the need for a reconceptualization of the relationship between cognition and function in mild cognitive impairment so that they can be usefully aligned.
- Published
- 2010
- Full Text
- View/download PDF
14. Calcium signaling in neurodegeneration.
- Author
-
Marambaud P, Dreses-Werringloer U, and Vingtdeux V
- Abstract
Calcium is a key signaling ion involved in many different intracellular and extracellular processes ranging from synaptic activity to cell-cell communication and adhesion. The exact definition at the molecular level of the versatility of this ion has made overwhelming progress in the past several years and has been extensively reviewed. In the brain, calcium is fundamental in the control of synaptic activity and memory formation, a process that leads to the activation of specific calcium-dependent signal transduction pathways and implicates key protein effectors, such as CaMKs, MAPK/ERKs, and CREB. Properly controlled homeostasis of calcium signaling not only supports normal brain physiology but also maintains neuronal integrity and long-term cell survival. Emerging knowledge indicates that calcium homeostasis is not only critical for cell physiology and health, but also, when deregulated, can lead to neurodegeneration via complex and diverse mechanisms involved in selective neuronal impairments and death. The identification of several modulators of calcium homeostasis, such as presenilins and CALHM1, as potential factors involved in the pathogenesis of Alzheimer's disease, provides strong support for a role of calcium in neurodegeneration. These observations represent an important step towards understanding the molecular mechanisms of calcium signaling disturbances observed in different brain diseases such as Alzheimer's, Parkinson's, and Huntington's diseases.
- Published
- 2009
- Full Text
- View/download PDF
15. Initial characterization of Chlamydophila (Chlamydia) pneumoniae cultured from the late-onset Alzheimer brain.
- Author
-
Dreses-Werringloer U, Bhuiyan M, Zhao Y, Gérard HC, Whittum-Hudson JA, and Hudson AP
- Subjects
- Aged, Aged, 80 and over, Astrocytes microbiology, Cell Line, Chlamydophila pneumoniae genetics, DNA, Bacterial genetics, Epithelial Cells microbiology, Female, Humans, Male, Microglia microbiology, Middle Aged, North America, Polymerase Chain Reaction methods, Polymorphism, Genetic, Sequence Analysis, DNA, Alzheimer Disease microbiology, Brain microbiology, Chlamydophila Infections microbiology, Chlamydophila pneumoniae isolation & purification
- Abstract
Previous studies from this laboratory provided evidence that the intracellular bacterial pathogen Chlamydophila (Chlamydia) pneumoniae is present in the late-onset Alzheimer's disease (AD) brain. Here we report culture of the organism from two AD brain samples, each of which originated from a different geographic region of North America. Culturable organisms were detectable after one and two passages in HEp-2 cells for the two samples. Both isolates, designated Tor-1 and Phi-1, were demonstrated to be authentic C. pneumoniae using PCR assays targeting the C. pneumoniae-specific genes Cpn0695, Cpn1046, and tyrP. Assessment of inclusion morphology and quantitation of infectious yields in epithelial (HEp-2), astrocytic (U-87 MG), and microglial (CHME-5) cell lines demonstrated an active, rather than a persistent, growth phenotype for both isolates in all host cell types. Sequencing of the omp1 gene from each isolate, and directly from DNA prepared from several additional AD brain tissue samples PCR-positive for C. pneumoniae, revealed genetically diverse chlamydial populations. Both brain isolates carry several copies of the tyrP gene, a triple copy in Tor-1, and predominantly a triple copy in Phi-1 with a minor population component having a double copy. This observation indicated that the brain isolates are more closely related to respiratory than to vascular/atheroma strains of C. pneumoniae.
- Published
- 2009
- Full Text
- View/download PDF
16. Therapeutic potential of resveratrol in Alzheimer's disease.
- Author
-
Vingtdeux V, Dreses-Werringloer U, Zhao H, Davies P, and Marambaud P
- Subjects
- Alzheimer Disease pathology, Animals, Antioxidants chemistry, Dementia drug therapy, Dementia pathology, Flavonoids chemistry, Flavonoids therapeutic use, Humans, Nerve Degeneration drug therapy, Nerve Degeneration pathology, Phenols chemistry, Phenols therapeutic use, Polyphenols, Resveratrol, Stilbenes chemistry, Wine, Alzheimer Disease drug therapy, Antioxidants therapeutic use, Stilbenes therapeutic use
- Abstract
Several epidemiological studies indicate that moderate consumption of red wine is associated with a lower incidence of dementia and Alzheimer's disease. Red wine is enriched in antioxidant polyphenols with potential neuroprotective activities. Despite scepticism concerning the bioavailability of these polyphenols, in vivo data have clearly demonstrated the neuroprotective properties of the naturally occurring polyphenol resveratrol in rodent models for stress and diseases. Furthermore, recent work in cell cultures and animal models has shed light on the molecular mechanisms potentially involved in the beneficial effects of resveratrol intake against the neurodegenerative process in Alzheimer's disease.
- Published
- 2008
- Full Text
- View/download PDF
17. Amyloid-beta peptide degradation in cell cultures by mycoplasma contaminants.
- Author
-
Zhao H, Dreses-Werringloer U, Davies P, and Marambaud P
- Abstract
Background: Cell cultures have become an indispensable tool in Alzheimer's disease research for studying amyloid-beta (Abeta) metabolism. It is estimated that up to 35% of cell cultures in current use are infected with various mycoplasma species. In contrast with common bacterial and fungal infections, contaminations of cell cultures with mycoplasmas represent a challenging issue in terms of detectability and prevention. Mycoplasmas are the smallest and simplest self-replicating bacteria and the consequences of an infection for the host cells are variable, ranging from no apparent effect to induction of apoptosis., Findings: Here we present evidence that mycoplasmas from a cell culture contamination are able to efficiently and rapidly degrade extracellular Abeta. As a result, we observed no accumulation of Abeta in the conditioned medium of mycoplasma-positive cells stably transfected with the amyloid-beta precursor protein (APP). Importantly, eradication of the mycoplasma contaminant - identified as M. hyorhinis - by treatments with a quinolone-based antibiotic, restored extracellular Abeta accumulation in the APP-transfected cells., Conclusion: These data show that mycoplasmas degrade Abeta and thus may represent a significant source of variability when comparing extracellular Abeta levels in different cell lines. On the basis of these results, we recommend assessment of mycoplasma contaminations prior to extracellular Abeta level measurements in cultured cells.
- Published
- 2008
- Full Text
- View/download PDF
18. A polymorphism in CALHM1 influences Ca2+ homeostasis, Abeta levels, and Alzheimer's disease risk.
- Author
-
Dreses-Werringloer U, Lambert JC, Vingtdeux V, Zhao H, Vais H, Siebert A, Jain A, Koppel J, Rovelet-Lecrux A, Hannequin D, Pasquier F, Galimberti D, Scarpini E, Mann D, Lendon C, Campion D, Amouyel P, Davies P, Foskett JK, Campagne F, and Marambaud P
- Subjects
- Aged, Aged, 80 and over, Amino Acid Sequence, Calcium Channels, Cell Membrane metabolism, Chromosomes, Human, Pair 10, Cytosol metabolism, Female, Genome, Human, Humans, Male, Membrane Glycoproteins chemistry, Middle Aged, Molecular Sequence Data, Phylogeny, Sequence Alignment, Alzheimer Disease genetics, Amyloid beta-Peptides metabolism, Calcium metabolism, Genetic Predisposition to Disease, Membrane Glycoproteins genetics, Membrane Glycoproteins metabolism, Polymorphism, Genetic
- Abstract
Alzheimer's disease (AD) is a genetically heterogeneous disorder characterized by early hippocampal atrophy and cerebral amyloid-beta (Abeta) peptide deposition. Using TissueInfo to screen for genes preferentially expressed in the hippocampus and located in AD linkage regions, we identified a gene on 10q24.33 that we call CALHM1. We show that CALHM1 encodes a multipass transmembrane glycoprotein that controls cytosolic Ca(2+) concentrations and Abeta levels. CALHM1 homomultimerizes, shares strong sequence similarities with the selectivity filter of the NMDA receptor, and generates a large Ca(2+) conductance across the plasma membrane. Importantly, we determined that the CALHM1 P86L polymorphism (rs2986017) is significantly associated with AD in independent case-control studies of 3404 participants (allele-specific OR = 1.44, p = 2 x 10(-10)). We further found that the P86L polymorphism increases Abeta levels by interfering with CALHM1-mediated Ca(2+) permeability. We propose that CALHM1 encodes an essential component of a previously uncharacterized cerebral Ca(2+) channel that controls Abeta levels and susceptibility to late-onset AD.
- Published
- 2008
- Full Text
- View/download PDF
19. Chlamydophila (Chlamydia) pneumoniae in the Alzheimer's brain.
- Author
-
Gérard HC, Dreses-Werringloer U, Wildt KS, Deka S, Oszust C, Balin BJ, Frey WH 2nd, Bordayo EZ, Whittum-Hudson JA, and Hudson AP
- Subjects
- Aged, Aged, 80 and over, Brain pathology, Case-Control Studies, Chlamydophila pneumoniae genetics, Chlamydophila pneumoniae isolation & purification, DNA, Bacterial analysis, Female, Humans, Immunohistochemistry, In Situ Hybridization, Male, Middle Aged, Alzheimer Disease microbiology, Brain microbiology, Chlamydia Infections complications, Chlamydophila pneumoniae pathogenicity
- Abstract
We assessed the presence and characteristics of the intracellular pathogen Chlamydophila (Chlamydia) pneumoniae in brain-tissue samples from 25 patients with late-onset Alzheimer's disease (AD) and 27 non-AD control individuals. 20/27 AD patients, but only 3/27 controls, were PCR-positive in multiple assays targetting the Cpn1046 and Cpn0695 genes. Culture of the organism from brain-tissue homogenate from one AD patient, and assessment of various chlamydial transcripts in RNA preparations from several patients, demonstrated that the organisms were viable and metabolically active in those samples. Immunohistochemical analyses showed that astrocytes, microglia, and neurons all served as host cells for C. pneumoniae in the AD brain, and that infected cells were found in close proximity to both neuritic senile plaques and neurofibrillary tangles in the AD brain. These observations confirm and significantly extend our earlier study suggesting that this unusual pathogen may play a role in the neuropathogenesis characteristic of AD.
- Published
- 2006
- Full Text
- View/download PDF
20. Chlamydophila (Chlamydia) pneumoniae infection of human astrocytes and microglia in culture displays an active, rather than a persistent, phenotype.
- Author
-
Dreses-Werringloer U, Gérard HC, Whittum-Hudson JA, and Hudson AP
- Subjects
- Astrocytes metabolism, Bacterial Proteins genetics, Cell Cycle genetics, Cell Line, Tumor, Chlamydophila Infections genetics, Chlamydophila Infections metabolism, Chlamydophila pneumoniae genetics, Chlamydophila pneumoniae growth & development, Chlamydophila pneumoniae pathogenicity, Gene Expression Regulation, Bacterial, Genes, Bacterial, Humans, Microglia metabolism, Organ Specificity, RNA, Bacterial biosynthesis, RNA, Bacterial genetics, RNA, Messenger biosynthesis, RNA, Messenger genetics, Reverse Transcriptase Polymerase Chain Reaction methods, Virulence, Astrocytes microbiology, Bacterial Proteins biosynthesis, Chlamydophila Infections microbiology, Chlamydophila pneumoniae metabolism, Microglia microbiology
- Abstract
Background: The intracellular pathogen Chlamydia pneumoniae can cause persistent infections during which its morphologic, molecular, and pathogenic characteristics differ importantly from those of active infection. This bacterium was identified within astrocytes and microglia in the brain of late-onset Alzheimer disease patients. We investigated whether infection of these two host cell types displays an active or persistent growth phenotype., Methods: The human astrocytoma and microglioma cell lines U-87 MG and CHME-5 (respectively) and the human epithelial cell line HEp-2 were infected by the standard method with C pneumoniae strain AR-39. Cultures were harvested at 24, 48, and 72 hours postinfection and subjected to analysis of inclusion morphology. DNA and RNA were prepared from portions of each infected culture sample and analyzed for relative chromosome accumulation and presence or absence of several specific bacterial mRNAs., Results: Astrocytes and microglial cells infected in vitro with C pneumoniae displayed inclusions that were indistinguishable from those characteristic of active infection of the standard HEp-2 host cell line. Real time polymerase chain reaction (PCR) showed that the relative accumulation of chlamydial chromosome over time during infection of these two cell lines also was virtually identical to that in actively infected HEp-2 cells. Reverse transcriptase PCR (RT-PCR) analyses showed that mRNA from ftsK, pyk, and other chlamydial genes whose expression is abrogated during persistent infection were easily identifiable in infected CHME-5 and U-87 MG cells., Conclusions: In cultured human astrocytes and microglia, C pneumoniae displays an active, not a persistent, growth phenotype. This indicates normal passage through the developmental cycle with its probable concomitant destruction by lysis of some portion of host cells at the termination of that cycle.
- Published
- 2006
- Full Text
- View/download PDF
21. Detection of nucleotide variability in rpoB in both rifampin-sensitive and rifampin-resistant strains of Chlamydia trachomatis.
- Author
-
Dreses-Werringloer U, Padubrin I, Köhler L, and Hudson AP
- Subjects
- Drug Resistance, Bacterial, Genes, Bacterial, Genetic Variation, Mutation, Antibiotics, Antitubercular pharmacology, Chlamydia trachomatis drug effects, Chlamydia trachomatis genetics, DNA-Directed RNA Polymerases genetics, Rifampin pharmacology
- Abstract
A 656-bp PCR fragment from rpoB was sequenced from five rifampin-resistant Chlamydia trachomatis variants selected in vitro from a wild-type parent with a surprising level of genetic variability in this region. Three variants (MIC, 4 microg/ml) showed Ala522-->Val in cluster I (codons 507 to 533), which harbors mutations in most rifampin-resistant bacteria. Two high-level resistance variants (MICs, 64 and 256 microg/ml) showed His526-->Tyr in cluster I with additional genetic variation, some of which resulted in amino acid substitutions. None of the latter was situated in clusters related to rifampin resistance in other bacteria.
- Published
- 2003
- Full Text
- View/download PDF
22. Effects of azithromycin and rifampin on Chlamydia trachomatis infection in vitro.
- Author
-
Dreses-Werringloer U, Padubrin I, Zeidler H, and Köhler L
- Subjects
- Antigens, Bacterial immunology, Cell Line, Chlamydia Infections microbiology, Chlamydia trachomatis growth & development, Electrophoresis, Polyacrylamide Gel, Fluorescent Antibody Technique, Direct, Humans, Immunoblotting, Microbial Sensitivity Tests, RNA, Ribosomal immunology, Reverse Transcriptase Polymerase Chain Reaction, Tumor Cells, Cultured, Anti-Bacterial Agents pharmacology, Antibiotics, Antitubercular pharmacology, Azithromycin pharmacology, Chlamydia Infections drug therapy, Chlamydia trachomatis drug effects, Rifampin pharmacology
- Abstract
An in vitro cell culture model was used to investigate the long-term effects of azithromycin, rifampin, and the combination of azithromycin and rifampin on Chlamydia trachomatis infection. Although standard in vitro susceptibility testing indicated efficient inhibition by azithromycin, prolonged treatment did not reveal a clear elimination of chlamydia from host cells. Chlamydia were temporarily arrested in a persistent state, characterized by culture-negative, but viable, metabolically active chlamydia, as demonstrated by the presence of short-lived rRNA transcripts. Additionally, azithromycin induced generation of aberrant inclusions and an altered steady-state level of chlamydial antigens, with the predominance of Hsp60 protein compared to the level of the major outer membrane protein. Treatment with azithromycin finally resulted in suppression of rRNA synthesis. Chlamydial lipopolysaccharide and processed, functional rRNA were detectable throughout the entire incubation period. These in vitro data show a good correlation to those from some recent clinical investigations that have reported on the persistence of chlamydia, despite appropriate antibiotic treatment with azithromycin. Rifampin was highly active by in vitro susceptibility testing, but prolonged exposure to rifampin alone for up to 20 days resulted in the emergence of resistance. No development of resistance to rifampin was observed when chlamydia-infected cells were incubated with a combination of azithromycin and rifampin. This combination was shown to be more efficient than azithromycin alone, in that suppression of rRNA synthesis occurred earlier. Thus, such a combination may prove more useful than azithromycin alone.
- Published
- 2001
- Full Text
- View/download PDF
23. Persistence of Chlamydia trachomatis is induced by ciprofloxacin and ofloxacin in vitro.
- Author
-
Dreses-Werringloer U, Padubrin I, Jürgens-Saathoff B, Hudson AP, Zeidler H, and Köhler L
- Subjects
- Antigens, Bacterial analysis, Cells, Cultured microbiology, Chlamydia trachomatis growth & development, Humans, Microbial Sensitivity Tests, Anti-Infective Agents pharmacology, Chlamydia trachomatis drug effects, Ciprofloxacin pharmacology, Ofloxacin pharmacology
- Abstract
An in vitro cell culture model was used to investigate the long-term effect of ciprofloxacin and ofloxacin on infection with Chlamydia trachomatis. Standard in vitro susceptibility testing clearly indicated successful suppression of chlamydial growth. To mimic better in vivo infection conditions, extended treatment with the drugs was started after infection in vitro had been well established. Incubation of such established chlamydial cultures with ciprofloxacin and ofloxacin not only failed to eradicate the organism from host cells, but rather induced a state of chlamydial persistence. This state was characterized by the presence of nonculturable, but fully viable, bacteria and the development of aberrant inclusions. In addition chlamydia exhibited altered steady-state levels of key chlamydial antigens, with significantly reduced major outer membrane protein and near constant hsp60 levels. Resumption of overt chlamydial growth occurred after withdrawal of ciprofloxacin, confirming the viability of persisting chlamydia. In vitro ciprofloxacin results are consistent with clinical data, thereby providing an explanation for treatment failures of ciprofloxacin. Parallel in vitro studies with ofloxacin suggest a better correlation between clinical and laboratory-defined efficacy, although the clinical studies on which this assessment is based did not include monitoring of chlamydial persistence. The data presented here clearly demonstrate that under at least some circumstances, standard determination of MICs and minimal bactericidal concentrations for C. trachomatis allows no more than a simple definition of whether an antibiotic has some anti chlamydial activity; however, such testing is not always sufficient to verify that the antibiotic will eliminate the organism in vivo.
- Published
- 2000
- Full Text
- View/download PDF
24. cDNA sequence and deduced amino acid sequence of the precursor of the 37-kDa inner envelope membrane polypeptide from spinach chloroplasts. Its transit peptide contains an amphiphilic alpha-helix as the only detectable structural element.
- Author
-
Dreses-Werringloer U, Fischer K, Wachter E, Link TA, and Flügge UI
- Subjects
- Amino Acid Sequence, Base Sequence, Chloroplast Proteins, Cloning, Molecular, Molecular Sequence Data, Molecular Weight, Protein Conformation, Protein Processing, Post-Translational, Solubility, Chloroplasts chemistry, DNA chemistry, Membrane Proteins genetics, Plant Proteins genetics, Plants genetics, Protein Precursors genetics
- Abstract
We present the nucleotide sequence and the deduced amino acid sequence of a cDNA clone that encodes the entire precursor of the 37-kDa inner envelope membrane protein from spinach chloroplasts. The precursor protein consists of 344 amino acids (Mr 38,976). In vitro processing followed by radiosequence analysis of the in vitro transcribed and translated precursor protein revealed that its transit peptide consists of only 21 amino acid residues. The transit peptide has the potential to form an amphiphilic alpha-helix with a strong hydrophobic moment. It is speculated that this structural element represents an ancestral envelope-targeting domain. The in vitro synthesized precursor protein is directed to the chloroplasts and it is inserted into the envelope membrane in an ATP-dependent manner. The mature protein (323 amino acid residues, Mr 36,830) has a moderate hydrophobicity and contains only one membrane-spanning segment which is located at the C-terminus and possibly anchors the protein within the envelope membrane.
- Published
- 1991
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.